Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-20-004581)

Filing Details

Accession Number:: 0001209191-20-004581
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-01-23 08:34:08
Reporting Period:: 2020-01-21

Accepted Time:: 2020-01-23 08:34:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1708493	Harpoon Therapeutics Inc.	HARP	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557930	Georgia Erbez	C/O Harpoon Therapeutics, Inc. 131 Oyster Point Boulevard, Suite 300 South San Francisco CA 94080	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-01-21	6,700	$14.09	6,700	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	47,292	Direct

Footnotes

Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory ("Erbez IRA Contributory"). The Reporting Person has beneficial ownership over these shares held by Erbez IRA Contributory.